Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial-Reference-Cited by-同舟云学术

Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial

Published:2018-10-25 Issue:2 Volume:15 Page:444-451
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Thompson Allison R.¹,Klein Nicola P.²,Downey H. Jackson³,Patterson Scott⁴,Sundaraiyer Vani⁵,Watson Wendy⁴,Clarke Keri⁶,Jansen Kathrin U.¹,Sebastian Shite¹,Gruber William C.¹,Scott Daniel A.⁴,Schmöele-Thoma Beate⁷^ORCID

Affiliation:

1. Pfizer Vaccine Clinical Research & Development, Pearl River, NY, USA

2. Kaiser Permanente Vaccine Study Center, Oakland, CA, USA

3. Jacksonville Center for Clinical Research, Jacksonville, FL, USA

4. Pfizer Vaccine Clinical Research & Development, Collegeville, PA, USA

5. Department of Biostatistics, Syneos Health, Princeton, NJ, USA

6. Pfizer Vaccine Research & Development, Tadworth, Surrey, UK

7. Vaccines Research and Development, Pfizer Pharma GmbH, Berlin, Germany

Funder

Pfizer

Publisher

Informa UK Limited